Where does Psomagen, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Psomagen, Inc. ranks #9,108 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Psomagen, Inc. hold?

Psomagen, Inc. holds 35 US utility patents granted between 2020 and 2024, spanning 16 technology areas.

What is Psomagen, Inc.'s Innovation Score?

Psomagen, Inc. has an Innovation Score of 40.2 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Psomagen, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Psomagen, Inc..

What does claim depth mean for Psomagen, Inc.'s patents?

Psomagen, Inc.'s patents average 18.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Psomagen, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Psomagen, Inc.

Q: What technology areas does Psomagen, Inc. focus on?

Psomagen, Inc.'s top technology area is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology) with 30 patents, ranking #21 of 676 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 35 granted patents across 16 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Psomagen ranks #9,108 of 49,997 tracked US assignees by granted-patent volume, with 35 patents across 16 technology areas.

#9,108
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.2/100): 18.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R9108 · US Corporation #9,108 · 35 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 35 grants
UPPER-Q #9,108/49,997
PHOTO-FINISH Polymer Technology…
CPC-FOCUS G16B · 16 areas
INNOV-PAR 40.2/100
CLAIMS-RICH 18.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Polymer Technology Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Psomagen’s 40.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.4 pts (31%) Velocity 2.7 pts (7%) Breadth 14.1 pts (35%) Claim depth 11.0 pts (27%)

Qualcomm Incorporated · highest

85
Applied Micro Circuits · near

40
CAP · near

40
CDE Global · near

40
Psomagen · this assignee

40
Biodesix · near

40
3D Lighting… · lowest

7

What this shows Psomagen's Innovation Score is 40.2/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Psomagen?

Each dot is one of Psomagen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Psomagen’s own 18.4 claims/patent is ABOVE the 15.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Psomagen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Psomagen's grants concentrate

Psomagen, Inc. is a focused PatentsView assignee: 16 CPC subclasses with 85.7% of grants classified under G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology). Peak complete grant year is 2020 (21 grants) versus a trough of 1 in 2022. By volume, Psomagen sits between Polymer Technology Systems, Inc. and Robert Welch Designs Ltd..

Psomagen's three-year grant acceleration

From 2019–2021 to 2022–2024, Psomagen, Inc. moved from 25 to 10 grants (0.40x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Polymer Technolog…

35
Portland State Un…

35
Profound Medical

35
Project Canary PBC

35
Rijksuniversiteit…

35
Raise Marketplace

35
Reciprocal Labs

35
Robert Welch Desi…

35
Psomagen ◀

35

What this shows Psomagen holds 35 patents at rank #9,107, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Psomagen

By rank, the assignees closest to #9,107 in granted patent volume.

Leaders in G16B (Bioinformatics)

Other assignees with the most granted patents in Psomagen's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Psomagen, neither rank-band nor same-CPC leaders (those blocks stay above). In G16B (Bioinformatics), Psomagen ranks #21 of 676 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

CAP Corporation 40 CDE Global Limited 40 Applied Micro Circuits Corporation 40 Biodesix, Inc. 40

Psomagen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Psomagen, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	21	60.0%
2021	4	11.4%
2022	1	2.9%
2023	6	17.1%
2024	3	8.6%

Which technologies does Psomagen, Inc. patent most?

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 30

Y02A - Technologies FOR Adaptation TO Climate Change 27

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 26

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 25

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

A61B - DIAGNOSIS; SURGERY; Identification 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 2

C07K - Peptides 1

B03C - Magnetic OR Electrostatic Separation OF Solid Materials From Solid Materials OR FLUIDS; Separation BY High-voltage Electric Fields 1

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 1

G06F - Electric Digital Data Processing 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Psomagen, Inc.'s patent record in context - here's where to go next.

Psomagen, Inc.'s lead technology class is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology), 85.7% of its portfolio - see every assignee active in that class. Explore G16B
Ranked #9,108 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Psomagen, Inc. against Polymer Technology Systems, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.